CD274 and myeloid sarcoma: NH patients also exhibited decreased counts of transitional B cells, known for their regulatory properties and potential to ameliorate MS severity (38), as well as reduced percentages of PD-L1+ monocytes, which exert immunomodulatory effects through inhibition of T cell activity (39).